CD274 and neoplasm: Although TRMT61A modestly impacted PD-L1 expression, tumor repression effects were marked, aligning with studies showing small immune checkpoint changes dramatically influence outcomes.17,54 Our results demonstrate that MYC-mediated PD-L1 translation modulation is the primary TRMT61A immunosuppression mechanism.